What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

Author: Steineck Gunnar   Glimelius Bengt  

Publisher: Informa Healthcare

ISSN: 0284-186X

Source: Acta Oncologica, Vol.52, Iss.8, 2013-11, pp. : 1589-1592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content